- Home
- JBLU vs LMAT Comparison
JBLU vs LMAT Comparison
Compare JBLU & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- LMAT
- Stock Information
- Founded
- JBLU 1998
- LMAT 1983
- Country
- JBLU United States
- LMAT United States
- Employees
- JBLU N/A
- LMAT N/A
- Industry
- JBLU Air Freight/Delivery Services
- LMAT Medical/Dental Instruments
- Sector
- JBLU Consumer Discretionary
- LMAT Health Care
- Exchange
- JBLU Nasdaq
- LMAT Nasdaq
- Market Cap
- JBLU 2.0B
- LMAT 2.0B
- IPO Year
- JBLU N/A
- LMAT 2006
- Fundamental
- Price
- JBLU $5.67
- LMAT $89.08
- Analyst Decision
- JBLU Hold
- LMAT Buy
- Analyst Count
- JBLU 10
- LMAT 6
- Target Price
- JBLU $6.31
- LMAT $92.60
- AVG Volume (30 Days)
- JBLU 17.0M
- LMAT 98.3K
- Earning Date
- JBLU 10-29-2024
- LMAT 10-31-2024
- Dividend Yield
- JBLU N/A
- LMAT 0.72%
- EPS Growth
- JBLU N/A
- LMAT 47.83
- EPS
- JBLU N/A
- LMAT 1.67
- Revenue
- JBLU $9,327,000,000.00
- LMAT $205,621,000.00
- Revenue This Year
- JBLU N/A
- LMAT $15.01
- Revenue Next Year
- JBLU $4.68
- LMAT $9.07
- P/E Ratio
- JBLU N/A
- LMAT $54.11
- Revenue Growth
- JBLU N/A
- LMAT 16.06
- 52 Week Low
- JBLU $3.42
- LMAT $45.96
- 52 Week High
- JBLU $8.07
- LMAT $93.32
- Technical
- Relative Strength Index (RSI)
- JBLU 38.78
- LMAT 55.00
- Support Level
- JBLU $6.86
- LMAT $84.69
- Resistance Level
- JBLU $7.49
- LMAT $92.84
- Average True Range (ATR)
- JBLU 0.37
- LMAT 2.05
- MACD
- JBLU -0.18
- LMAT -0.07
- Stochastic Oscillator
- JBLU 0.46
- LMAT 75.21
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.